Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.     

Metabolic and production responses to dietary protein and exogenous somatotropin in late gestation dairy cows.

Forty-three multiparous Holstein cows were used in a completely randomized design to evaluate the effects of protein supplementation and the use of bovine somatotropin (bST; Posilac, Monsanto Co., St. Louis, MO) in late gestation on animal metabolism and productivity in the periparturient period. Treatments were initiated 28 d prior to expected calving date and continued through parturition. Diets contained either 13.3 or 17.8% crude protein and were formulated to be similar in profile of protein fractions. Within each dietary treatment, cows were assigned to receive either 0 or 500 mg of sustained released bST once every 14 d until parturition. Following parturition, all cows were subjected to the same management and dietary treatments, and production measurements were followed until 42 d in milk. The use of bST increased plasma glucose and decreased plasma nonesterified fatty acids and beta-hydroxybutyrate prior to calving. Despite these changes in metabolism, bST did not affect concentrations of fat and triglyceride in the liver prepartum or postpartum. Feeding the 17.8% protein diet failed to stimulate glucose metabolism and tended to elevate plasma beta-hydroxybutyrate in late gestation. Cows treated with bST produced 3.3 kg/d more milk than did controls across the first 42 d of lactation; the difference was 4.6 kg/d in wk 6 of lactation. The use of bST in late gestation has considerable promise to alter cow metabolism positively. The results of these and other possible periparturient responses to somatotropin may increase milk production in early lactation.     

Monensin and growth hormone effects on glucose metabolism in the prepartum cow

Twenty-seven multiparous Holstein dairy cows were used to evaluate the singular and combined effects of somatotropin and monensin treatments during the late dry period on postpartum metabolism and production. Treatments were 1) control, 2) injection of exogenous bovine somatotropin (bST); 3) total mixed rations top-dressed with 300 mg of monensin/d, and 4) monensin and somatotropin in combination, during the last 28 d before expected parturition. A 500-mg subcutaneous injection of sustained-release somatotropin was administered at d-28 and -14 relative to expected calving. Glucose kinetics was evaluated on d 15 before expected calving date using a tracer dose of 45 mg of U-13C-labeled glucose. Jugular blood was sampled 20 times during 8 h after tracer injection. Intake of DM was 1.9% of BW, and daily feed was supplied in six equal meals before the glucose kinetic assay. The CONSAM simulation program, which assumes a two-compartment model, was used to analyze the glucose 13C enrichment curves with time. Average glucose distribution space, glucose mass, and glucose residence time in compartment 1 were increased in monensin-treated cows and were decreased in bST-treated cows. On the day of the glucose kinetic assay, blood concentrations of glucose, NEFA, and urea were similar among treatments. The changes in glucose pool and distribution space suggest that monensin increases propionate supply and bST facilitates glucose flow into glucose consuming organs. It is concluded that dairy cows might benefit from a combined application of monensin and bST before parturition.     

Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.     

Effects of phytonutrients alone or in combination with monensin on productivity in lactating dairy cows

This experiment was conducted to investigate the effects of phytonutrients, compared with monensin as a positive control, on productivity, milk fatty acids, fat mobilization, and blood cells in lactating dairy cows. Thirty-six Holstein cows were used in a 9-wk randomized complete block design study. Following a 2-wk covariate period, cows were blocked by days in milk, parity, and milk yield and randomly assigned to 1 of 3 treatments (12 cows/treatment): 450 mg/cow per day of monensin (MO), 250 mg/cow per day of capsicum plus 450 mg/cow per day of MO (MOCAP), and 1,000 mg/cow per day of a mixture of cinnamaldehyde, eugenol, and capsicum (CEC). Dry matter intake and milk yield were not affected by treatment. Supplementation of CEC increased feed efficiency compared with MO, but did not affect feed efficiency on an energy-corrected milk basis. Milk composition (fat, protein, and lactose), milk fatty acid profile, and blood concentrations of nonesterified fatty acids and β-hydroxybutyrate were also not affected by treatment. The expression of hormone-sensitive lipase in adipose tissues tended to increase for MOCAP compared with MO. Counts of total white blood cell, neutrophils, lymphocytes, eosinophils, and basophils were not affected by treatment, although monocytes count tended to be decreased by CEC. Treatments had no effect on red blood cells, hemoglobin, and platelets. Results indicate that dietary supplementation of CEC and capsicum had no production or other effects in dairy cows, compared with MO, except CEC increased feed efficiency and tended to decrease blood monocytes count.     

Production and blood parameters of Holstein cows treated prepartum with sodium monensin or propylene glycol

Forty-five multiparous Holstein cows were assigned to one of 3 treatments in a randomized complete block design. The objective was to evaluate the effects of sodium monensin (M) and propylene glycol (PPG) during the prepartum period on performance and metabolic parameters during the late dry and first 9 wk postpartum for cows receiving M postpartum. Treatments were: control (C), M in a controlled-release capsule to deliver 335 +/- 33 mg/d for approximately 100 d, and 300 mL/d of PPG drenched orally. Treatments started at 35 and 21 d prior to the expected date of calving for cows receiving M and PPG, respectively. To ensure that all treatments would be restricted to the prepartum period, C and PPG cows received a M controlled-release capsule in the first 24 h after calving. Prepartum propylene glycol administration increased concentrations of glucose and insulin, and decreased beta-hydroxybutyrate and nonesterified fatty acids in plasma prepartum. Milk production was similarly affected by treatments. However, prepartum M treated cows tended to produce more 3.5% fat-corrected milk compared with control, but similar to PPG. Milk fat content and yield tended to be greater for cows that received M prepartum than for C cows, while PPG cows were similar to M and C. Prepartum administration of M decreased milk protein content, but no effect was observed on protein yield.     

Effects of bovine somatotropin and evaporative cooling plus shade on lactation performance of cows during summer heat stress

Thirty-two Holstein cows (8 per treatment) averaging 195 d in milk were assigned to 70 d of treatment on the basis of production during a 14-d pretreatment period, which was used for covariate analysis. The experiment was a randomized block design with a 2 x 2 factorial arrangement of treatments. Factors were normal shade or shade plus evaporative cooling with pressurized spray, plus with or without the administration of bovine somatotropin (bST). Cows receiving bST were injected with 500 mg of bST every 14 d. All cows were fed the same total mixed rations twice daily at approximately 10% in excess of appetite, and water was offered free choice. There were no interactions between bST and the cooling system for any of the variables measured. Milk yield was increased by bST and tended to be greater for cooled cows. Fat percentages were increased by bST, and yields of fat, protein, and 3.5% fat-corrected milk, and the efficiency of conversion of dry matter to milk, whereas evaporative cooling increased body weights and protein yields, but decreased SNF and milk protein percentages. Rectal temperatures and respiration rates also were lower for cooled cows. And, bST increased nonesterified fatty acids in blood serum, suggesting that a part of the energy for increased milk production came from mobilization of body fat. Administration of bST effectively improved performance of cows under hot summer conditions whether evaporatively cooled or not.     

Short communication: Hepatic gene expression for gluconeogenic enzymes in lactating dairy cows treated with bovine somatotropin

Eight lactating Holstein dairy cows (80 d in milk) were used to examine the effects of exogenous bovine somatotropin (bST) on hepatic contents of mRNA encoding pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), and microsomal triglyceride transfer protein (MTP). Concentrations of bST in plasma were higher and milk production increased 20% in bST-treated cows. Liver samples from cows treated with bST had significantly higher total lipid contents than those from control cows. Although there were small numerical tendencies, neither triglyceride concentrations in liver nor nonesterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), or glucose in plasma differed significantly between bST-treated and control cows. Short-term bST treatment had no detectable effects on contents of PC, PEPCK, and MTP mRNA in the liver. In summary, exogenous bST stimulation of milk production is not mediated through enhanced liver gluconeogenesis, but may involve partitioning of glucose and fatty acids for preferential use by the mammary gland.     

Effects of feeding frequency and exogenous somatotropin on lipolysis, hormone profiles, and milk production in dairy cows

Effects of feeding frequency and exogenous bovine somatotropin on lactational performance and hormone profiles were examined with 12 multiparous Holstein cows. At 45 d postpartum, cows were assigned to one of two feeding systems. Concentrates were offered in two equal portions at 0800 and 1600 h or in 12 equal portions at 2-h intervals. Chopped alfalfa hay (2.6 kg/d) and barley silage (ad libitum) were fed at 0900 and 1500 h. At 136 d postpartum, cows within each feeding frequency were assigned in a single crossover design to injection of 30 mg of bST/d or solubilization vehicle. Feeding frequency did not influence any of the parameters measured nor did bST interact with feeding frequency. Somatotropin injection increased daily milk yield of cows by 4.4 kg and concentrations of fat and lactose in milk. Protein concentration and fatty acid composition of milk were not influenced by bST injection. Average plasma somatotropin concentrations were elevated threefold, peak concentrations were increased sevenfold, and concentrations at 48 h postinjection were 1.5 times control values. Plasma insulin concentrations were decreased by bST treatment. Results indicate that responses to short-term bST injection are not influenced by feeding frequency.     

Peripartal metabolism and production of holstein cows fed diets supplemented with fat during the dry period

Previous research from our laboratory demonstrated that cows fed supplemental fat throughout the dry period in an attempt to increase body condition score (BCS) had little hepatic lipid accumulation at d 1 postpartum compared with cows fed an isocaloric high-grain diet or a lower energy control diet. However, results were confounded by lower dry matter intake and loss of BCS by cows fed the fat-supplemented diet. Here, cows were fed a control diet (C) moderately high in nonfiber carbohydrates (NFC) or an isocaloric fat-supplemented, low NFC (F) diet to reassess the effects of supplemental fat throughout the dry period on peripartal lipid accumulation in liver. A more energy-dense, high-NFC diet supplemented with fat (CF) was also fed to test the efficacy of supplemental fat in a diet with similar carbohydrate composition but higher energy density. Intakes of dry matter and net energy for lactation were similar among treatments throughout the experiment, although diet x day interactions during the last 21 d before parturition indicated that cows fed CF decreased intakes more slowly. Cows gained similar amounts of BCS and body weight among diets prepartum, but cows fed C tended to lose more BCS and body weight around parturition. Milk production and milk components did not differ among treatments. Prepartum concentrations of glucose, insulin, total protein, nonesterified fatty acids, and mu-hydroxybutyrate in plasma were similar among treatments. Supplemental fat increased prepartum concentrations of urea and cholesterol in plasma. Postpartum concentrations of metabolites and insulin in plasma were similar among treatments. Concentrations of total lipid and triglyceride in liver increased at parturition, whereas hepatic glycogen concentration decreased, but concentrations were not different among treatments. Supplemental fat fed prepartum did not affect peripartal lipid accumulation in liver tissue and did not benefit postpartum milk production.     

Effect of added dietary fat and bovine somatotropin on the performance and metabolism of lactating dairy cows

Four early lactation Holstein cows (44 to 105 d postpartum) were used in a 4 X 4 Latin square experiment in a 2 X 2 factorial arrangement of treatments to study effects of added dietary fat and/or bovine somatotropin on performance and metabolism. Treatments were: 1) control diet plus placebo injection; 2) 5% added dietary fat (hydrolyzed blend of animal and vegetable fat) + placebo injection; 3) control diet + 50 IU bovine somatotropin/d; and 4) 5% added dietary fat + 50 IU bovine somatotropin/d. Dietary fat reduced dry matter intake (21.6 vs. 22.7 kg/d) and elevated plasma triglycerides (34.7 vs. 29.2 mg/100 ml). Injection of somatotropin lowered blood urea nitrogen, increased plasma free fatty acids, and increased plasma somatotropin. Milk production, milk fat percent, and 4% FCM production were increased by the injection of somatotropin. Milk protein percent was decreased (3.30 vs. 3.44%) with added fat and tended to be lower with somatotropin. The percentage of short-chain fatty acids (C6 to C14) in milk fat decreased with added fat while the percentage of stearic and oleic acids in milk fat increased. Production responses for fat plus somatotropin and somatotropin treatments were similar. Under the conditions of this study, the addition of dietary fat with injection of somatotropin had little effect on production parameters compared with that found with somatotropin alone.     

Effects of propylene glycol or fat drench on plasma metabolites,liver composition,and production of dairy cows during the periparturient period

Forty-eight Holstein cows were used to determine the effects of short-term oral drenches of propylene glycol (PG) and Ca-soaps of palm oil fatty acids (fat) on plasma concentrations of key metabolites, liver composition, and milk production during the first 3 wk of lactation. Treatments (2 x 2 factorial arrangement) given orally once daily for the first 3 d postpartum were water (control), 500 ml of PG, 454 g of fat, or 500 ml of PG plus 454 g of fat. All treatments were administered as a total volume of 1.9 L. Administration of PG decreased concentrations of nonesterified fatty acids (NEFA) in plasma during the first 7 d and the first 21 d postpartum and tended to decrease concentrations of beta-hydroxybutyrate during the first 7 d postpartum. Concentrations of insulin in plasma were not affected by treatment. Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments. Concentrations of triglycerides in liver were not affected by treatment. Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum; however, cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation. Short-term drenching of PG effectively decreased NEFA concentrations in plasma during early lactation; however, data do not support administration of fat via drench to early lactation cows and concurrent administration of dietary fat appears to blunt the metabolic response of cows to PG.     

Composition and flavor of milk and butter from cows fed unsaturated dietary fat and receiving bovine somatotropin.

Composition and flavor of milk and butter were evaluated from cows divided into four treatments including a control, control with bST, added dietary fat from sunflower seeds with bST, or added dietary fat from safflower seeds with bST. Feeding added unsaturated dietary fat resulted in lower concentrations of short-and medium-chain and higher concentrations of long-chain fatty acids in milk fat and butter. Milk fat unsaturated fatty acid concentrations were 25.0, 28.4, 39.6, and 37.9%, and butter unsaturated fatty acid concentrations were 23.0, 26.9, 37.8, and 36.2% for control, control with bST, sunflower seeds with bST, and safflower seeds with bST, respectively. Sensory evaluations indicated that butters from the bST with sunflower seed and bST with safflower seed treatments were equal or superior in flavor to the control butter. Milk from cows receiving bST or fed added unsaturated dietary fat and receiving bST was no more susceptible to oxidized off-flavors than control milk. Butters from sunflower seed and safflower seed treatments with bST contained higher concentrations of unsaturated fatty acids, were softer at 4 and 20 degrees C, and possessed acceptable flavor and processing characteristics compared with butters from control and control with bST.     

Effects of prepartum diets varying in dietary energy density and monensin on early-lactation performance in dairy cows

Our objectives were to evaluate the effects of prepartum monensin supplementation and dry-period nutritional strategy on the postpartum productive performance of cows fed monensin during lactation. A total of 102 Holstein cows were enrolled in the experiment (32 primiparous and 70 multiparous). The study was a completely randomized design, with randomization restricted to balance for parity, body condition score, and expected calving date. A 2 × 2 factorial arrangement of prepartum treatments was used; the variables of interest were prepartum feeding strategy [controlled-energy diet throughout the dry period (CE) vs. controlled-energy diet from dry-off to 22 d before expected parturition, followed by a moderate-energy close-up diet from d 21 before expected parturition through parturition (CU)] and prepartum monensin supplementation [0 g/t (control, CON) or 24.2 g/t (MON); Rumensin; Elanco Animal Health, Greenfield, IN]. Lactation diets before and after the dry period contained monensin at 15.4 g/t. During the close-up period, cows fed CU had greater DM and NE_L intakes than cows fed CE. Calf BW at birth tended to be greater for cows fed CU than for those fed CE but was not affected by MON supplementation. Diet did not affect calving difficulty score, but cows supplemented with MON had an increased calving difficulty score. We found a tendency for a MON × parity interaction for colostral IgG concentration, such that multiparous MON cows tended to have lower IgG concentration than CON cows, but colostral IgG concentration for primiparous MON and CON cows did not differ. Postpartum milk yield did not differ between diets but tended to be greater for cows supplemented with MON. Milk fat and lactose content were greater for cows fed CU than for those fed CE, and lactose content and yield were increased for cows supplemented with MON. Solids-corrected and fat-corrected milk yields were increased by MON supplementation, but were not affected by diet. Overall means for postpartum DMI did not differ by diet or MON supplementation. The CU diet decreased the concentration of nonesterified fatty acids during the close-up period but increased it postpartum. Neither diet nor monensin affected β-hydroxybutyrate or liver composition. Overall, postpartum productive performance differed little between prepartum dietary strategies, but cows fed MON had greater energy-corrected milk production. In herds fed monensin during lactation, monensin should also be fed during the dry period.     

Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon

The main objective of this study was to test the extent to which injecting glucagon subcutaneously for 14 d beginning at d 2 postpartum would prevent fatty liver development in transition dairy cows. Twenty-four multiparous Holstein cows were fed 6 kg of cracked corn in addition to their standard diet during the last 30 d of a dry period to induce postpartum development of fatty liver. Glucagon at either 7.5 or 15 mg/d or saline (control) was injected subcutaneously 3 times daily for 14 d beginning at d 2 postpartum. Glucagon at 15 mg/d prevented liver triacylglycerol accumulation in postpartum dairy cows. Glucagon at 7.5 mg/d showed potential for fatty liver prevention. Glucagon increased concentration of plasma glucose and insulin and decreased plasma nonesterified fatty acid concentrations. No effects of glucagon were detected on plasma β-hydroxybutyrate concentrations. Glucagon affected neither feed intake nor milk production. Moreover, milk composition was not altered by glucagon. Milk urea N concentrations decreased, and plasma urea N concentrations tended to decrease during glucagon administration, indicating that glucagon may improve protein use. Liver glycogen concentrations were not affected by glucagon. No significant differences in body condition scores were detected among treatments throughout the study. These results indicate that subcutaneous glucagon injections can prevent fatty liver in transition dairy cows without causing major production and metabolite disturbances.     

Effects of grain processing and bovine somatotropin on metabolism and ovarian activity of dairy cows during early lactation

This study compared the effects of exogenous bovine somatotropin (bST) on the metabolism and ovarian activity of cows fed diets differing in ruminally degradable starch. Twenty-four multiparous and eight primiparous Holstein cows in early lactation were divided into four groups and fed diets containing 39% grain as steam-flaked sorghum or steam-rolled corn with or without bST for 90 d in a 2 x 2 factorial design. Flaked sorghum improved energy status of cows during early lactation, tending to increase plasma glucose and insulin. Administration of bST decreased plasma urea nitrogen and increased nonesterified fatty acids (NEFA). Plasma levels of beta-hydroxybutyrate (BHBA) and hepatic concentrations of triglycerides were not altered by treatments. Temporal changes in plasma glucose, urea nitrogen, NEFA, and BHBA were detected in a quadratic manner and insulin increased linearly with time, but treatments did not affect postpartum changes in these metabolites. There were greater decreases in body weight and net energy balance in cows on bST during the first 7 wk of treatment. Cows receiving bST took longer to reach the nadir of negative energy balance, and bST tended to delay the period to reach a positive energy balance. Follicular populations and incidence of cystic ovaries were not affected by treatments, but cows receiving bST had fewer double ovulations. Flaked sorghum increased plasma progesterone during the early luteal phase of the first two postpartum estrous cycles. Feeding more ruminally degradable starch improved the energy status and luteal activity of cows in early lactation.     

Individual variation in the milk yield response to bovine somatotropin in dairy cows

The objective was to relate the short-term milk yield response (MYR) following use of exogenous bovine somatotropin (bST) to changes in plasma concentrations of metabolites and hormones. Twenty-four Holstein cows (52 +/- 4.1 d postpartum) received daily subcutaneous injections of saline for 1 wk followed by subcutaneous injections of 33 mg/d of bST for 2 wk (Trial 1). The difference in milk yield between wk 1 and 3 for each cow was used to determine the 5 cows with the highest (HR) and 5 with the lowest responses (LR) to bST. These 10 cows were then used in 3 further trials of the same design (Trials 2, 3, and 4, conducted at 122, 181, and 237 +/- 7.6 d postpartum, respectively). Blood samples were taken 2 h after the administration of bST on d 1, 3, 5, 15, 17, and 19 of each trial. The HR group had consistently greater MYR to bST than the LR group throughout their lactation. The LR group had a higher milk yield and lower plasma insulin like growth factor-I (IGF-I) concentrations during the saline treatment in all trials. The increase in plasma somatotropin concentrations following injections of bST was greater for the LR group, whereas the difference in plasma IGF-I level between wk 1 and 3 was greater for the HR group. The HR group had lower levels of 3-hydroxy-butyrate and nonesterified fatty acids before bST treatment. Low short-term response to bST was associated with plasma concentrations of hormones and metabolites that indicate negative energy balance, although other factors may be involved.     

Peripartum responses of dairy cows fed energy-dense diets for 3 or 6 weeks prepartum

Pregnant cows (n = 189) in two commercial dairy farms were assigned randomly to be fed energy-dense diets for either 3 or 6 wk before expected calving. Cows fed diets for less than or equal to 26 d were designated the short (S) treatment group, and those fed greater than 26 d were the long (L) treatment group. Cows in L tended to have improved energy status during the first 2 wk postpartum, as indicated by higher insulin concentrations and a tendency for lower nonesterified fatty acid concentrations. Treatment did not affect plasma beta-hydroxybutyrate concentrations. Cows in L tended to gain more body condition during the late dry period. Total body condition loss from parturition through 6 wk postpartum was not different between treatments, but the rate of change varied over this period. Cows in S lost more body condition during the first 3 wk postpartum than cows in L. In farm 1 only, cows in L lost more body condition from 3 to 6 wk postpartum and had a higher incidence of metritis and a longer interval to first service than cows in S. Cows in L had higher milk protein content through 60 d in milk compared with cows in S. Additionally, cows in L in farm 1 produced 4.4 kg/d less milk, tended to have lower milk fat content and yields, and higher somatic cell counts through 150 d in milk than cows in S. Overall, increasing the length of time cows were fed the energy-dense diet prepartum elicited significant changes in farm 1, but had little effect in farm 2. Based on these results, L treatment may improve energy status immediately postpartum, but long-term effects varied between farms, perhaps due to other unmeasured management differences.     

Effect of rumen-protected niacin on lipid metabolism, oxidative stress, and performance of transition dairy cows

The objective of this study was to evaluate the effect of a rumen-protected niacin product (RPN; 65% nicotinic acid; NiaShure, Balchem Corp., New Hampton, NY) on lipid metabolism, oxidative stress, and performance of transition dairy cows. Thirty nonlactating multiparous Holstein cows in late gestation were paired according to expected calving date and randomly assigned to 12 g/cow per day of RPN product or to an unsupplemented control (CON) diet. Treatment diets were fed from 21 d before expected calving through 21 d after parturition. Blood samples were taken on d -21, -14, -7, 1, 7, 14, and 21 relative to calving for plasma nonesterified fatty acid (NEFA), β-hydroxybutyrate (BHBA), glucose, and superoxide dismutase (SOD) analyses. Liver samples were taken by biopsy on d 1 and 21 relative to calving for triglyceride (TG) analysis. Data were analyzed for a randomized complete block design with repeated measures. Pre- and postpartum dry matter intake, milk yield, and protein were unaffected by treatment. Milk fat percentage (5.08 vs. 4.44%) and somatic cell score (3.93 vs. 2.48) were reduced for RPN. Treatment × time interactions were observed for energy-corrected milk (ECM) and fat-corrected milk (FCM) yields; RPN reduced ECM and FCM yields by 8.5 and 8.9 kg/cow per day, respectively, in the first week of lactation. Although body weight and condition score decreased during the experimental period, no differences due to treatment were observed. However, calculated postpartum energy balance tended to be improved for RPN because of the reduction in ECM yield. Time and treatment × time effects were observed for plasma NEFA. On d 1 postpartum, NEFA reached 1,138±80 μEq/L for CON compared with 698±80 μEq/L for RPN. Cows supplemented with RPN tended to have lower plasma NEFA concentrations than CON cows on d 7 and 14 postpartum. Plasma BHBA, glucose, and SOD and liver TG concentrations were unaffected by treatment. In conclusion, supplementation with 12 g/cow per day of the RPN product provided a bioavailable source of niacin that modified lipid metabolism but did not affect milk yield over the first 3 wk of lactation or oxidative stress of transition dairy cows.     

Dietary supplements of two doses of calcium salts of conjugated linoleic acid during the transition period and early lactation

Reduction of milk fat secretion by the use of conjugated linoleic acid (CLA) supplements may alleviate energy demands during early lactation. The objective of the present study was to evaluate lactational performance, net energy balance, and reproductive response of dairy cows supplemented with 2 doses of CLA from 2 wk before predicted calving until 9 wk postpartum. Holstein cows (n = 48) were divided into 3 treatment groups: 1) control, 2) low dose CLA treatment (CLA-1), and 3) high dose CLA treatment (CLA-2). Supplements for all treatments provided 230 g/d of fat; the control group received Ca salts of palm fatty acid distillate and the CLA groups received a mixture of Ca salts of CLA isomers and Ca salts of palm fatty acid distillate (31.6 and 63.2 g/d of CLA isomers for CLA-1 and CLA-2, respectively). Supplementation with CLA resulted in an 11 and 21% decrease in milk fat yield for CLA-1 and CLA-2, respectively. Milk production and secretion of other milk components did not differ among treatments. Milk energy output was significantly reduced with CLA-2, but net energy balance, body weight, and body condition scores were unaffected. Treatment had no effect on hepatic triglyceride concentration or plasma glucose and insulin, but nonesterified fatty acids tended to be lower for CLA-1. There were no consistent dose-related effects on reproduction variables, and no adverse effects were observed during the treatment or posttreatment period. Supplemental CLA was effective in reducing milk fat content, but it did not have a significant effect on milk yield or net energy balance.